Tag: HEICO Corporation

Finance

Big Moves in Focus: Qihoo 360 Technology (NYSE:QIHU), HEICO Corporation (NYSE:HEI-A), First Acceptance (NYSE:FAC), Twitter Inc (NYSE:TWTR), Whiting USA Trust II (NYSE:WHZ)

Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) announced it has formed a strategic partnership with Coolpad Group Limited (“Coolpad”) (HKSE: 2369), a leading smartphone company in China, through investing $409.05 million in cash to take a 45% stake in a joint venture with Coolpad (the “JV”). Qihoo 360 Technology Co. Ltd. (NYSE:QIHU) belongs to Technology sector. Its net profit margin is 15.00% and weekly performance is … Continue reading Big Moves in Focus: Qihoo 360 Technology (NYSE:QIHU), HEICO Corporation (NYSE:HEI-A), First Acceptance (NYSE:FAC), Twitter Inc (NYSE:TWTR), Whiting USA Trust II (NYSE:WHZ)

Colin Pettis
Finance

Hot Alert: Gold Fields Ltd. (NYSE:GFI), Sprint Corporation (NYSE:S), Flowserve Corp. (NYSE:FLS), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), HEICO Corporation (NYSE:HEI)

Gold Fields Limited (Gold Fields) (NYSE:GFI) on 20 October 2014 published updated production guidance for the Group for the September 2014 quarter (Q3 2014). Attributable gold equivalent production for the quarter is expected to be approximately 559,000 ounces at All-in Sustaining Costs (AISC) of US$1,074/oz and All-in Costs (AIC) of US$1,096/oz. Gold Fields Ltd. (NYSE:GFI) belongs to Basic Materials sector. Its net profit margin is … Continue reading Hot Alert: Gold Fields Ltd. (NYSE:GFI), Sprint Corporation (NYSE:S), Flowserve Corp. (NYSE:FLS), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), HEICO Corporation (NYSE:HEI)

Jayne Crisman
Finance

Hot News : Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), CalAmp Corp. (NASDAQ:CAMP), Phillips 66 (NYSE:PSX), HEICO Corporation (NYSE:HEI), BlackBerry Ltd (NASDAQ:BBRY)

Alder BioPharmaceuticals (NASDAQ:ALDR) announced data from the proof-of-concept clinical trial of ALD403 published in the October 6, 2014 issue of Lancet Neurology demonstrates that ALD403 met the primary study endpoint and is effective for the preventative treatment of migraine. ALD403 is Alder’s lead clinical candidate targeting the calcitonin gene-related peptide, or CGRP, for migraine prevention. CGRP is a small protein that is critically important in … Continue reading Hot News : Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), CalAmp Corp. (NASDAQ:CAMP), Phillips 66 (NYSE:PSX), HEICO Corporation (NYSE:HEI), BlackBerry Ltd (NASDAQ:BBRY)

Mark Doerr